Homo sapiens Protein: PMM2 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-13920.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | PMM2 | ||||||||||||||||||
Protein Name | phosphomannomutase 2 | ||||||||||||||||||
Synonyms | CDG1; CDG1a; CDGS; PMI; PMI1; PMM 2; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000268261 | ||||||||||||||||||
InnateDB Gene | IDBG-13918 (PMM2) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. {ECO:0000250}. | ||||||||||||||||||
Subcellular Localization | Cytoplasm. | ||||||||||||||||||
Disease Associations | Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 1A is an autosomal recessive disorder characterized by a severe encephalopathy with axial hypotonia, abnormal eye movement, and pronounced psychomotor retardation, as well as peripheral neuropathy, cerebellar hypoplasia, and retinitis pigmentosa. Patients show a peculiar distribution of subcutaneous fat, nipple retraction, and hypogonadism. {ECO:0000269PubMed:10066032, ECO:0000269PubMed:10571956, ECO:0000269PubMed:10602363, ECO:0000269PubMed:10801058, ECO:0000269PubMed:11058895, ECO:0000269PubMed:11058896, ECO:0000269PubMed:11350185, ECO:0000269PubMed:12357336, ECO:0000269PubMed:15844218, ECO:0000269PubMed:17307006, ECO:0000269PubMed:9140401, ECO:0000269PubMed:9497260, ECO:0000269PubMed:9781039}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR005002
Eukaryotic phosphomannomutase IPR006379 HAD-superfamily hydrolase, subfamily IIB IPR023214 HAD-like domain |
||||||||||||||||||
PFAM |
PF03332
PF00702 PF08282 PF13419 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART | |||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O15305 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O15305 | ||||||||||||||||||
TrEMBL | H3BV55 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 5373 | ||||||||||||||||||
UniGene | Hs.731165 | ||||||||||||||||||
RefSeq | NP_000294 | ||||||||||||||||||
HUGO | HGNC:9115 | ||||||||||||||||||
OMIM | 601785 | ||||||||||||||||||
CCDS | CCDS10536 | ||||||||||||||||||
HPRD | 03472 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AC012173 AF157790 AF157791 AF157792 AF157793 AF157794 AF157795 AF157796 AK291537 AK296630 BC008310 CH471112 U85773 | ||||||||||||||||||
GenPept | AAC51368 AAD45895 AAH08310 BAF84226 BAH12405 EAW85202 EAW85203 | ||||||||||||||||||